Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Nutraceutical

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1442548

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1442548

Heart Health Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 244 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

Description

Table of Contents

The global market for heart health supplements is poised for substantial growth over the forecast period from 2024 to 2031, with a projected Compound Annual Growth Rate (CAGR) of 5.0%. According to comprehensive market analysis, the revenue is expected to surge from US$ 11 billion in 2024 to approximately US$ 15 billion by 2031.

Key Trends Driving Growth:

  • Increasing Customer Preference Toward Non-GMO Supplements: Consumer concerns over genetically modified foods have led to a significant shift in preference towards non-GMO supplements. Manufacturers are responding to this trend by offering products validated by the non-GMO Project. For instance, Coenzyme Q10, a non-GMO verified product supporting cardiovascular health, has gained traction among health-conscious consumers.
  • Increased Positioning for Natural Supplements: Consumers are increasingly inclined towards natural products, driven by concerns over synthetic ingredients and their potential health impacts. The market has witnessed a rise in the demand for heart health supplements sourced from natural ingredients, reflecting a broader trend towards natural and wholesome nutrition.
  • Rising Consumer Awareness Toward Healthy Lifestyle: Growing awareness about the importance of healthy lifestyles has fueled demand for supplements that support heart health. With obesity and cardiovascular diseases on the rise globally, consumers are seeking products that offer nutritional benefits and aid in disease prevention.
  • Increased Production of Synthetic Dietary Supplements to Restrict Market Growth: While synthetic dietary supplements have gained popularity due to their ease of production and lower costs, their consumption is facing resistance from consumers demanding naturally-sourced alternatives. Concerns over potential side effects and the lack of potent benefits compared to natural supplements are driving this shift in consumer preference.

Country-wise Insights:

The global market for heart health supplements is poised for significant growth during the forecast period. Established markets like North America, holding a share of 44.9% in 2023, are leading the way due to increased consumer awareness about preventive healthcare and the rising prevalence of lifestyle diseases.

Moreover, emerging economies such as India, Brazil, Mexico, Malaysia, China, and Indonesia are experiencing notable economic growth. In tandem with this economic change, there's been a surge in consumer awareness regarding health consciousness and the consumption of dietary supplements. These countries are witnessing a considerable uptick in the consumption of heart health supplements, fueled by factors such as rising purchasing power among consumers, accessibility to various brands, and increasing online sales of these supplements. This trend is contributing to a favorable market outlook for heart health supplements in these regions.

Category-wise Insights:

Online retail sales of heart health supplements are projected to experience a higher value CAGR of 6.6% over the forecast period, fueled by growing internet penetration and the convenience of online shopping. Additionally, the liquid form of supplements is expected to witness significant growth due to changing consumer preferences and the demand for alternative dosage forms.

Segmental Breakdown:

The global heart health supplements market is segmented by form, ingredient, and sales channel. Forms include powder, liquid, softgel, and pills, while ingredients encompass vitamins and minerals, amino acids, botanical supplements, and others. Sales channels include hypermarkets/supermarkets, drug & specialty stores, online retail, and other retail formats.

Competitive Analysis:

Leading manufacturers in the heart health supplements market are focusing on expansion strategies such as acquisitions and product diversification to strengthen their market presence. Additionally, innovation remains a key driver, with companies launching new products aligned with evolving consumer preferences and market trends.

Key companies profiled

  • Bayer AG
  • USANA Health Sciences, Inc.
  • Sanofi
  • Koninklijke DSM N.V.
  • Pfizer Inc.
  • Abbott Laboratories
  • Herbalife Nutrition Ltd.
  • GNC Holdings Inc
  • Chr. Hansen Holding A/S
  • BASF SE
  • Amway
  • NOW Health Group, INC.
  • Nutramax Laboratories, INC.
  • The Nature's Bounty Co.
  • Nature's Way Products, LLC.
  • Viva Naturals
  • NutraMarks, Inc.
  • Vitabiotics Ltd
  • Vitamin Shopee, Inc.
  • Pure Encapsulations, LLC

Heart Health Supplements Industry Research by Category

By Form:

  • Powder
  • Liquid
  • Soft Gels & Pills

By Ingredient:

  • Vitamins & Minerals
  • Amino Acids
  • Botanical Supplements
  • Others

By Sales Channel:

  • Hypermarkets/Supermarkets
  • Drug & Specialty Stores
  • Online Retail
  • Other Retail Formats

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Heart Health Supplements Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Heart Health Supplements Market Outlook, 2018 - 2031

  • 3.1. Global Heart Health Supplements Market Outlook, by Form, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Powder
      • 3.1.1.2. Liquid
      • 3.1.1.3. Soft Gels & Pills
  • 3.2. Global Heart Health Supplements Market Outlook, by Ingredient, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Vitamins & Minerals
      • 3.2.1.2. Amino Acids
      • 3.2.1.3. Botanical Supplements
      • 3.2.1.4. Others
  • 3.3. Global Heart Health Supplements Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hypermarkets/Supermarkets
      • 3.3.1.2. Drug & Specialty Stores
      • 3.3.1.3. Online Retail
      • 3.3.1.4. Other Retail Formats
  • 3.4. Global Heart Health Supplements Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Heart Health Supplements Market Outlook, 2018 - 2031

  • 4.1. North America Heart Health Supplements Market Outlook, by Form, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Powder
      • 4.1.1.2. Liquid
      • 4.1.1.3. Soft Gels & Pills
  • 4.2. North America Heart Health Supplements Market Outlook, by Ingredient, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Vitamins & Minerals
      • 4.2.1.2. Amino Acids
      • 4.2.1.3. Botanical Supplements
      • 4.2.1.4. Others
  • 4.3. North America Heart Health Supplements Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hypermarkets/Supermarkets
      • 4.3.1.2. Drug & Specialty Stores
      • 4.3.1.3. Online Retail
      • 4.3.1.4. Other Retail Formats
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Heart Health Supplements Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Heart Health Supplements Market Outlook, 2018 - 2031

  • 5.1. Europe Heart Health Supplements Market Outlook, by Form, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Powder
      • 5.1.1.2. Liquid
      • 5.1.1.3. Soft Gels & Pills
  • 5.2. Europe Heart Health Supplements Market Outlook, by Ingredient, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Vitamins & Minerals
      • 5.2.1.2. Amino Acids
      • 5.2.1.3. Botanical Supplements
      • 5.2.1.4. Others
  • 5.3. Europe Heart Health Supplements Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hypermarkets/Supermarkets
      • 5.3.1.2. Drug & Specialty Stores
      • 5.3.1.3. Online Retail
      • 5.3.1.4. Other Retail Formats
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Heart Health Supplements Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Heart Health Supplements Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Heart Health Supplements Market Outlook, by Form, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Powder
      • 6.1.1.2. Liquid
      • 6.1.1.3. Soft Gels & Pills
  • 6.2. Asia Pacific Heart Health Supplements Market Outlook, by Ingredient, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Vitamins & Minerals
      • 6.2.1.2. Amino Acids
      • 6.2.1.3. Botanical Supplements
      • 6.2.1.4. Others
  • 6.3. Asia Pacific Heart Health Supplements Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hypermarkets/Supermarkets
      • 6.3.1.2. Drug & Specialty Stores
      • 6.3.1.3. Online Retail
      • 6.3.1.4. Other Retail Formats
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Heart Health Supplements Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Heart Health Supplements Market Outlook, 2018 - 2031

  • 7.1. Latin America Heart Health Supplements Market Outlook, by Form, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Powder
      • 7.1.1.2. Liquid
      • 7.1.1.3. Soft Gels & Pills
  • 7.2. Latin America Heart Health Supplements Market Outlook, by Ingredient, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Vitamins & Minerals
      • 7.2.1.2. Amino Acids
      • 7.2.1.3. Botanical Supplements
      • 7.2.1.4. Others
  • 7.3. Latin America Heart Health Supplements Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hypermarkets/Supermarkets
      • 7.3.1.2. Drug & Specialty Stores
      • 7.3.1.3. Online Retail
      • 7.3.1.4. Other Retail Formats
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Heart Health Supplements Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Heart Health Supplements Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Heart Health Supplements Market Outlook, by Form, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Powder
      • 8.1.1.2. Liquid
      • 8.1.1.3. Soft Gels & Pills
  • 8.2. Middle East & Africa Heart Health Supplements Market Outlook, by Ingredient, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Vitamins & Minerals
      • 8.2.1.2. Amino Acids
      • 8.2.1.3. Botanical Supplements
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa Heart Health Supplements Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hypermarkets/Supermarkets
      • 8.3.1.2. Drug & Specialty Stores
      • 8.3.1.3. Online Retail
      • 8.3.1.4. Other Retail Formats
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Heart Health Supplements Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Heart Health Supplements Market by Form, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Heart Health Supplements Market by Ingredient, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Heart Health Supplements Market by Sales Channel, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs Indication Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Bayer AG
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. USANA Health Sciences, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Sanofi
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Koninklijke DSM N.V.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Pfizer Inc.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Abbott Laboratories
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Herbalife Nutrition Ltd.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. GNC Holdings Inc
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Chr. Hansen Holding A/S
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. BASF SE
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Amway
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. NOW Health Group, INC.
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Nutramax Laboratories, INC.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. The Nature's Bounty Co.
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Nature's Way Products, LLC.
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!